期刊文献+

高温联合顺铂及多西他赛对肺腺癌A549细胞体外作用的研究 被引量:5

The effect of hyperthermia combined with cisplatin and docetaxel on human lung cancer cell line A549 in vitro
暂未订购
导出
摘要 目的:研究高温联合顺铂(DDP)及多西他赛(TXT)对肺腺癌细胞株A549的体外作用。方法:不同处理因素作用于A549细胞后,应用四氮唑盐比色法(MTT法)测定细胞增殖情况,根据Veleriote法判断高温联合化疗药的作用效果;通过两药相互作用指数判断药物联合作用效果;流式细胞仪检测不同处理后细胞凋亡情况;光学显微镜及荧光显微镜观察细胞形态学变化。结果:高温和化疗药单独作用均对A549有生长抑制作用(P<0.05);化疗药有剂量依赖关系;高温有温度依赖关系;高温与药物联合对细胞生长抑制作用强于单独高温组或单独化疗组(P<0.01);DDP与高温联合为协同作用;TXT与高温联合为次加作用;DDP和TXT联合作用对细胞生长抑制为协同作用;42℃、DDP2μg/ml和TXT1μg/ml三者联合凋亡率明显高于其他处理组(P<0.01);普通光镜和荧光显微镜下42℃、DDP2μg/ml和TXT1μg/ml三者联合凋亡细胞数较对照组和42℃组明显增多,细胞形态学变化明显。结论:DDP、TXT、高温三者体外联合作用对A549有明显的生长抑制和诱导凋亡作用。 Objective:To study the synergistic effect of combined use of cisplatin, docetaxel and hyperthermia on human lung adenocarcinoma A549 cell in vitro. Method : A549 cell was treated with different drugs , temperatures. Cell viability and growth were measured by means of MTr assay. The effect of combined use of cisplatin, docetaxel and hyperthermia were examined by means of morphologic observation and flow cytometry (FCM). Results: The signifi- cantly proliferation inhibition effect were observed when using either hyperthermia or drugs alone( P 〈 0.05 ) ,with a temperature or dose - dependent manner. Hyperthermia enhanced the proliferation inhibition rates compare with drug alone(P 〈0.01 ). Significant synergistic effect was observed when cisplatin combined with docetaxel. The apoptosis ratio of combined use of cisplatin 2tLg/ml,docetaxel 1 ~g/ml at 42~C was higher than other groups. The results were coincident with morphologic observation. Conclusion: Synergistic antitumor effects of combined use of cisplatin, do- cetaxel and hyperthermia on A549 were prior to other groups , including significantly proliferation inhibition and apop- tosis induction.
出处 《现代肿瘤医学》 CAS 2010年第5期857-861,共5页 Journal of Modern Oncology
关键词 顺铂 多西他赛 高温 肺癌 cisplatin docetaxel hyperthermia lung cancer cell lihe A549
  • 相关文献

参考文献11

  • 1Othman T,Goto S,Lee JB,et al.Hyperthermic enhancement of the apoptotic and antiproliferative activities of paclitaxel[J].Pharmacology,2001,62(4):208-212.
  • 2Gahai VL,Mosina VA,Budagova KR,et al.Spontaneous overexpresion of heat shock protein in Ehrlich ascutes carcinoma cells during in vivo growth[J].Biochem Mol Biol Int,1995,35:95-102.
  • 3孙跃民,傅军,张伟,郑朝旭,黄常志,袁兴华.温热化疗对胃、结肠癌细胞的体外作用研究[J].癌症,2006,25(8):974-978. 被引量:3
  • 4盛修贵,汤玲,李大鹏,李慧芹,宋现让,路春华,王兴武,李庆水.人子宫内膜癌体外化学药物敏感性的实验研究[J].中华肿瘤杂志,2004,26(7):409-412. 被引量:5
  • 5Istomin YP,Zhavrid EA,Alexandrova EN,et al.Dose enhancement effect of anticaner drugs associated with increased temperature in vitro[J].Exp Oncol,2008,30(1):56-59.
  • 6周际昌.实用肿瘤内科学[M].北京:人民卫生出版社.2006:47
  • 7Hettinga JV,Konings AW,Kampinga HH.Reduction of cellular cisplatin resistance by hyperthermia-a review[J].Int J Hyperthermia,1997,13(5):439-457.
  • 8孙胜杰,焦顺昌,魏秀芳.42℃温热增强顺铂对人肺癌细胞PLA-801D毒性的实验研究[J].现代肿瘤医学,2006,14(5):539-542. 被引量:23
  • 9Ramalingam SS,Khuri FR.The role of the taxanes in the treatment of older patients with advanced stage non-small cell lung cancer[J].Oncologist,2009,14(4):412-424.
  • 10de Bree E,Theodoropoulos PA,Rosing H,et al.Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes:from laboratory bench to bedside[J].Cancer Treat Rev,2006,32(6):471-482.

二级参考文献28

  • 1黄伟,张瑶珍,周剑锋,刘文励.顺铂和阿霉素对K562细胞周期及凋亡影响的研究[J].中国病理生理杂志,2005,21(3):537-540. 被引量:5
  • 2魏国,方国恩,毕建威,申晓军,聂明明,薛绪潮,华积德.胃癌术中低渗温热腹腔化疗联合术后早期腹腔化疗的疗效观察[J].癌症,2005,24(4):478-482. 被引量:22
  • 3雷通海 何兆毅.中国恶性肿瘤死亡率20年变化趋势图[J].中国肿瘤,1997,6(6):3-5.
  • 4Witkamp A J, de Bree E, Van Goethem R, et al. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy [J]. Cancer Treat Rev, 2001,27(6):365-374.
  • 5Glehen O, Mohamed F, Gilly F N. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia [J]. Lancet Oncol, 2004,5(4) :219-228.
  • 6Kuhn J A, McLoughlin J M, Harris D C, et al. Intraperitoneal hyperthermic chemotherapy: experience at Baylor University Medical Center [ J ]. Proc (Bayl Univ Med Cent), 2002,15 (4) :359-362.
  • 7Verwaal V J, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer [J]. J Clin Oncol, 2003,21 (20) : 3737-3743.
  • 8Glehen O, Schreiber V, Cotte E, et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer [J]. Arch Surg,2004,139( 1 ) : 20-26.
  • 9Glehen O, Stuart O A, Mohamed F, et al. Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model[J]. Cancer Chemother Pharmaco, 2004,54( 1 ) : 79-84.
  • 10Verwaal V J, Boot H, Aleman B M, et al. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy:location, treatment, and outcome [J]. Ann Surg Oncol, 2004,11 (4) : 375-379.

共引文献82

同被引文献58

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部